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Background: The Swedish National Patient Registry (NPR) is a nationwide registry that is
used extensively for epidemiological research. Using the NPR, we recently found a recurrent
pregnancy loss (RPL) incidence of 650/100,000 (0.65%) pregnant women in Sweden. It is of
great importance that the quality of the coding is good and reliable in order to use NPR data
for research. To specifically study RPL in Sweden, a general validation of this diagnosis in
the NPR is needed.
Objective: To validate the diagnosis of RPL, defined as ≥3 consecutive miscarriages before
22 gestational weeks, recorded in the NPR and assess how registered miscarriages were
verified clinically (ultrasound or urine/serum hCG) by reviewing the medical records.
Materials and methods: In a cohort of 6,852 women diagnosed with RPL in Sweden,
during 2003–2012, a total of 238 complete medical records from 38 hospitals were reviewed.
A power calculation estimated that 228 medical records had to be reviewed for a positive
predictive value (PPV) of 85% (95% CI) with a power of 90%. The ICD-10 diagnoses used
for RPL were N96.9 and O26.2.
Results: The diagnosis of RPL was confirmed in 202 out of 238 medical records resulting in
a PPV of 85% (95% CI 78–89%) out of which 59% were verified with ultrasound whereas
35% were verified only by urine/serum hCG.
Conclusion: The Swedish NPR is a valuable tool for epidemiological research. We found a
high PPV of RPL in the NPR, supporting the use of these data for future research.
Keywords: abortius habitualis, recurrent pregnancy loss, validation study, registries,
epidemiology
Introduction
Miscarriage is one of the most common early pregnancy complications. When it
happens repeated times it is not only bad luck but is considered as a disease defined
as recurrent pregnancy loss (RPL).1–3 RPL is traditionally defined as three or more
consecutive miscarriages before the fetus reaches viability, ie, before 22 gestational
weeks.4 Recently the definition has been debated and changed by the European
Society of Human Reproduction and Embryology (ESHRE) and the Practice
Committee of the American Society for Reproductive (ASRM) to as few as two
miscarriages.2,5–7
The prevalence of RPL is stated to be 0.5–2.3%,1,2,8–10 and the incidence has
been estimated at 650/100,000 pregnant women based on the results from a retro-
spective register study in Sweden.11 Estimating the incidence of RPL is somewhat
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difficult because of a lack of consensus regarding the
definition of RPL but also due to uncertainty about
whether to include biochemical miscarriages (positive
urinary human chorionic gonadotropin (hCG), a raised
serum hCG) or only clinical miscarriages verified with
ultrasound or histology.2,3,12,13 The above incidence of
RPL in Swedish women is to our knowledge the first
study on the RPL incidence11,13 as others report an occur-
rence or a prevalence of PRL.1,9 The incidence based on
registers will also depend on if women with miscarriage
get in contact with a physician in the health care system.13
This often happens if bleeding occurs in early pregnancy
or a routine scan is performed.
Women and/or couples with RPL are often in distress.
However, a possible explanation for why they miscarry is
only found in 40–50% of the cases. Parental chromosomal
translocations, congenital and acquired uterine abnormal-
ities, endocrine imbalances, autoimmune factors including
the antiphospholipid syndrome, as well as infections and
thrombophilia, are all possible causes.10,12,14,15
Many epidemiological studies on RPL are observational
and based on data from registers that are available for research
purposes. Such studies are also important to improve the
quality of health care, and to manage health care services.16,17
One such register is the Swedish National Patient
Register (NPR), which was used in the above incidence
study on RPL.11,17 Clearly, it is important that the data in
the registers are valid and representative. A recent review
stated that the accuracy for many diseases in the NPR
register ranged from 85% to 95%.16
To our knowledge, there is no evidence regarding the
precision of RPL in the NPR. Such evidence is essential
for the use and interpretation of RPL based on NPR data.
The aim of this study was to validate the ICD-10 diag-
noses codes registered in the NPR for RPL (N96.9,
O26.2). A secondary aim was to analyze whether only
miscarriages verified by ultrasound or also pregnancy
losses verified only by urine or serum hCG are registered
in the NPR and used for the RPL diagnosis.
Material and methods
Study design
A cross-sectional observational study designed was used
to validate the RPL diagnosis registered in the NPR com-
pared with the information obtained in the medical
records. The medical records were considered as “refer-
ence standard”. In order to assess whether a diagnosis of
RPL was defined as three or more consecutive miscar-
riages, the medical records were reviewed.
The main aim was to evaluate the positive predictive
value (PPV), defined as the proportion of women regis-
tered as RPL in the NPR with a diagnosis verified by
information from medicals records. Sensitivity was
assessed and defined as the proportion of women suffering
RPL and registered with the diagnosis in the NPR.
Population
In our previous study, a cohort of 6,852 women was
diagnosed with RPL in the NPR over a 10-year period in
Sweden.11 We assumed that only one-third of the medical
records requested from hospitals would be available and/or
would provide the necessary information. A sample size of
711 women, registered with the ICD-10 diagnoses codes
N96.9 and/or O26.2 were randomly selected by the
National Board of Health and Welfare (NBHW), who are
responsible for the NPR (Figure 1).
Data sources
The NPR includes information about hospitalization,
recorded at discharge. Each record states admission and
discharge dates, hospital department, and the primary and
up to seven contributory diagnoses coded according to the
Swedish versions of the current edition (at the time of
diagnosis) of the International Classification of Diseases
(ICD).17
NBHW is the Swedish agency that administrates and is
responsible for the NPR. Reporting information to the
NPR is mandatory and is delivered to the NBHW once a
month from each of the 21 county councils in Sweden.
Since 1987, the NPR has included all inpatient events in
Sweden. Since 2001, the register has also covered out-
patient visits, including both private and public caregivers.
The coverage of in-patients is currently almost 100%. For
hospital-based outpatients, data from some private care-
givers are missing, so the total cover for outpatients is
considerably lower (approximately 80%).16,18
The samples selected byNBWHwere received encrypted
with the 10-digit personal identification number assigned to
all Swedish residents, as well as a hospital and clinic code.
The selected hospitals provided a variation in demographic
characteristics from larger university hospitals to smaller
regional hospitals with geographic representation from all
regions. All relevant available clinics were contacted to
obtain the medical records. Consent was secured from the
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head of each clinic. The medical secretary or archive staff at
the hospitals provided the medical records by registered mail.
The first author reviewed the medical records and the RPL
diagnoses (N96.9 and O26.2) were compared and validated
against data in the NPR.
In our previous incidence study, an estimation was made
of how many women, registered with three or more con-
secutive miscarriages, ie, fulfilling the diagnostic criteria of
RPL, lacked the registered diagnosis codes of RPL (N96.9,
O26.2) in the NPR.11 This group comprised women, with-
out an RPL diagnosis in the register, with three or more of
the following ICD codes for miscarriages (main or bi-diag-
nosis) without interspersed live births: O02.1, O03 (includ-
ing sub-diagnosis O03.0–O03.9) during 2003 and 2012.11
Since the same diagnosis can be used several times on
different occasions when contacting the healthcare system
about the same pregnancy, a 90-day interval was required
between two registered diagnoses of miscarriage to count as
a new miscarriage. This group of women, with three or
more consecutive miscarriages fulfilling the diagnostic cri-
teria for RPL, but without registration in the NPR as RPL,
are considered “false negative” and are used for calculating
the sensitivity of RPL in the NPR.
Variables used
The method of diagnosing miscarriage: ultrasound exam-
ination or diagnosis based on a positive hCG-test, as well
as method of conception: spontaneous or in vitro-fertiliza-
tion pregnancy, were evaluated. Furthermore, the distribu-
tion regarding primary or secondary RPL and known risk
factors for RPL were also evaluated.
Statistical analysis
The accuracy of positive register diagnoses of RPL was
determined by PPV, ie, the probability of positive registered
cases being confirmed by the medical records (reference
standard). The PPV was calculated as: [true positive register
cases] divided by [true positive in reference standard] plus
[false-positive register cases] with 2×2 cross tables and a χ-
square test with 95% confidence intervals (95% CI).
The ability of the registers to detect women with three
or more consecutive miscarriages (“true positive”) was
determined by sensitivity, ie, the probability of positive
cases ever appearing in the register with a diagnosis of
RPL. Sensitivity was calculated as: [true positive register
cases] divided by [true positive register cases] plus [false
Figure 1 Flowchart of women diagnosed with recurrent pregnancy loss in the national patient register and validated with medical records.
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negative register cases] with 2×2 cross tables and a χ-
square test with a 95% CI.
A power analysis, assuming that PPV would be 85%
and the accepted width of a 95% CI was 10 percentage
units (eg, 80–90%), calculated that a sample size of 228
medical records were needed to achieve a power of 90%.
All data were analyzed using SPSS version 24
(Armonk, NY: IBM Corp.)
Ethics
The Regional Ethical Board at Lund University (Lund,
Sweden) approved the national study (Dnr 2016/478).
Results
In the randomly selected cohort of 711 women, registered
with RPL in the NPR, 485 medical records were requested
from 60 different hospitals and private caregivers. Out of
the 60 hospitals, 73% of the university hospitals, 60% of
the regional hospitals and 50% of the private caregivers
responded. In total, 254 medical records were available for
review from 38 hospitals. In 16 cases, the medical records
were not conclusive regarding the correctness of the diag-
noses as information was missing (Figure 1). Correct
diagnosis was made in 202 out of the 238 medical records,
resulting in PPV (202/238)=85% (95% CI 78–89%) (Table
1). Out of the remaining 36 women with incorrect diag-
nosis, 27 cases (16+4+1 (Table 1)) could have been
included as correct if the definition of two miscarriages
had been used to qualify as RPL.
In our previous study about RPL incidence,11 a cohort
consisting of 990 women had had three consecutive mis-
carriages during 2003–2012 but with missing RPL
diagnosis in the NPR. These women were defined as
“false negative“ as they fulfilled the criteria for the diag-
noses of RPL but were not registered as such in the NPR. In
the same study,11 a cohort of 6,852 women was diagnosed
with RPL in the NPR during the 10-year period. With a
PPV of 85%, estimated in this current study, the number of
“true positives” in the cohort registered with RPL was
calculated to be 5,824 women (0.85*6,852=5,824). For
calculating sensitivity, “true positive” was divided by “true
positive” plus “false negative” which gave 5,824/(5,824
+990)=0.85, ie, a sensitivity of 85%.
Pregnancy variables were evaluated among the women
who were correctly diagnosed (n=202) (Table 2). One
hundred and twenty (59%) women had their miscarriage
verified with ultrasound, whereas for 70 (35%) it was
verified only by urine/serum hCG. There were 100
women (50%) without known risk factors for RPL. One
hundred and eleven (55%) and 88 (44%) women had
primary and secondary RPL, respectively.
Discussion
This validation study for RPL diagnosis registered in the
Swedish NPR showed 85% PPV and a sensitivity of 85%.
The findings are important for future research using data
from the NPR in general and on RPL specifically. The data
confirm our previous incidence study.11
To our knowledge, no other studies have evaluated the
data quality of registered RPL in national health registers.
To avoid selection bias and confounding factors, our valida-
tion study was conducted with data from a large number of
hospitals from different regions in Sweden. The responding
rate for university hospitals (73%) and regional hospitals
Table 1 Validation of RPL diagnosis in medical records, randomly selected from women diagnosed with RPL in the NPR
Diagnoses in medical records Number of
cases, n
Positive predictive value %
(95% CI)
Total medical records reviewed 238
3 consecutive miscarriages 202 85 (80–89%)
Incorrect diagnoses 36 –
– 3 non-consecutive miscarriages 7
– Only 2 miscarriages 16
– 1 of the 3 miscarriages was a IUFD (>gw.22) 4
– 1 of the 3 miscarriages was a termination of pregnancy because of chromo-
some abnormality
1
– 1 or 0 miscarriages 7
– Other reason 1
Abbreviations: RPL, recurrent pregnancy loss; ICD, International Classification of Diseases; NBHW, National Board of Health and Welfare (responsible for the NPR);
NPR, national patient register; IUFD, intrauterine fetal demise; gw, gestational week.
Rasmark Roepke et al Dovepress
submit your manuscript | www.dovepress.com
DovePress
Clinical Epidemiology 2019:11378
(60%) was pretty similar. There was a good geographic and
demographic distribution of the participating hospitals so
the material of the responded hospital can be considered
representative and one of the strengths of the study.
Some medical records (n=16) were not conclusive
regarding whether the RPL criteria were met or not.
Furthermore, there were a substantial number of medical
records (n=231) that could not be obtained. As high as
37% of the hospitals did not respond to the request to
participate, a factor that might skew the results if there is
a difference in the accuracy of diagnosing RPL in those
who responded and those who did not. There are no
obvious defined characteristics in the hospitals that did
not respond compared to those that did respond that
could suspect an influence in the results.
Despite these minor weaknesses, the power estimation
of 228 medical records was reached in the study. Only one
physician reviewed the medical records and consequently,
no cross-reading of the medical records was possible. Such
a cross-reading could have strengthened the study further
and could also have enabled an inter-observational sub-
analysis of the validated diagnoses.
The proportion of valid diagnoses, ie, PPV, in the NPR
is probably higher in patients with severe as opposed to
mild diseases.16 RPL is considered as a benign diagnosis,
and taking this into consideration, the estimated PPV of
RPL in the current study is fully acceptable and in line
with the overall accuracy for several other diseases regis-
tered in the NPR.16
Sensitivity concerns how complete a register is and how
good the register is at capturing cases with a disease.19 To
assess the sensitivity a random population should be studied
for the disease and then there should be a crosscheck to see
whether individuals with the disease are recorded in the
Table 2 Women with correct diagnosis of recurrent pregnancy loss and pregnancy variables
Variables Number of women (%)
(Total n: 202)
Method for verifying pregnancy
All three pregnancies verified by ultrasound 120 (59)
One or more pregnancies only verified by hCG measurement 70 (35)
Unknown 12 (6)
Conception method
3 spontaneous 186 (92)
2 spontaneous +1 IVF 5 (2.5)
2 or 3 IVF 11 (5.5)
Possible cause of RPL
Uterine malformation 5 (2.5)
Uterine septae 11 (5.5)
Uterine fibroma 3 (1.5)
Uterine polyp 3 (1.5)
Uterine synechiae 5 (2.5)
Hypothyroidism 7 (3.5)
Parental chromosomal translocation 8 (4)
Antiphospholipid syndrome (positive anticardiolipin antibodies or lupus anticoagulant) 5 (2.5)
Cervical insufficiency 1 (0.5)
Thrombophilia 4 (2)
None found 100 (50)
Not examined 49 (24)
RPL
Primary 111 (55)
Secondary 88 (44)
Tertiary 1 (0.5)
Inconclusive 2 (1)
Abbreviations: hCG, human choriogonadotropin; IVF, in vitro fertilization; RPL, recurrent pregnancy loss; Primary RPL, no children before recurrent miscarriages;
Secondary RPL, childbirth before recurrent miscarriages; Tertiary RPL, recurrent pregnancy loss with childbirth after and subsequently again recurrent pregnancy loss.
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register. Many women suffer miscarriages without contact-
ing a hospital or another caregiver and therefore do not exist
in medical records.20 It was not possible to study a random
population for “false negative” cases; instead, we used data
from our previous study describing the incidence of RPL.11
This might be considered less accurate than the first men-
tioned sensitivity assessment, as it was dependent on coding
of miscarriages in the NPR.
Whether a woman with RPL is reported in the NPR
depends on several factors, including the care-seeking
behavior of an individual, access to health care, and the
physician’s awareness of the disease. Hospital fees can be
an issue in some countries but since they are relatively low
in Sweden this factor is of less importance. The NPR
coding is also used as the basis for management and
financing, and some ICD codes give higher financial com-
pensation than others. The effects of financial incitements
on ICD coding have probably been underestimated.16 To
our knowledge, there have not been any significant
changes in financial compensation for miscarriage or
RPL codes over the last few decades.
Coding in registers is also associated with errors such as
not having a better code to use and typing mistakes when
documenting the code.21 Ludvigsson et al presented three
types of diagnostic coding error in medical records; I) diag-
nostic errors, ie, the patient received an incorrect diagnosis,
II) translation errors, ie, the ICD code in the NPR is different
from the code actually listed in the patient chart, and III)
coding errors, ie, a faulty ICD code accompanies an other-
wise correct diagnosis.16
If two miscarriages had been used to define RPL as
suggested by the ESHRE and the ASRM Practice
Committee,6,7 the PPV would have been higher.
However, the definition of RPL used in Sweden during
this period was three or more miscarriages. Our search in
the NPR included diagnoses from both in- and outpatient
records, although most women with a miscarriage or RPL
are treated as outpatients. The NPR started registering
outpatients in 2001 and according to the NBHW, the
register is reliable for the period 2003–2005. It would,
therefore, have been interesting to stratify the diagnoses
by year and analyze whether any differences in the vali-
dation parameters for RPL changed over the years.
However, this information was not possible to obtain
and a stratification could therefore not be performed.
The negative predictive value and specificity could not
be estimated in this study, as the numbers of “true nega-
tives” were unknown.
Only 59% of the pregnancies were verified with ultra-
sound, which is interesting considering that some scientific
societies require a clinical pregnancy (verified by ultrasound
or histopathology) as part of the definition.7 Thirty-five per-
cent of the women with RPL had at least one of the pregnan-
cies confirmed by hCG only and many of these would not
have been given the RPL diagnosis in the opinion of the
ASRM Practice Committee.7 This mode of confirmation is,
however, acceptable according to ESHRE’s RPL 2018 guide-
line for pregnancies past six gestational weeks with heavy
bleeding.6 According to this definition, the verified pregnan-
cies used in this study are therefore correctly defined.
In half of the women who were verified with a RPL
diagnosis in the medical record, no possible risk factor for
RPL was found. This is in line with other studies reporting
on the RPL etiology.15,22 Of the women, 55% and 44%
had experienced primary and secondary RPL, respectively,
which is also in line with previously reported data.11
Conclusion
The data indicate that the obtained PPV and sensitivity for
the RPL diagnosis in the Swedish NPR have high quality
and are therefore useful to use for future RPL research.
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